Literature DB >> 15860690

Ziprasidone pretreatment attenuates the lethal effects of cocaine in a mouse model.

Nathan J Cleveland1, Christopher D Dewitt, Kennon Heard.   

Abstract

BACKGROUND: Cocaine intoxication is a common cause of agitation in emergency department patients. Ziprasidone, an atypical antipsychotic, is being increasingly used for sedation of agitated patients in the emergency department.
OBJECTIVES: To provide preliminary animal data on the efficacy of ziprasidone for the treatment of acute cocaine poisoning.
METHODS: This was a randomized, blinded comparison of ziprasidone and placebo for the prevention of seizures and apparent lethality in a mouse model of cocaine intoxication. Animals were assigned to either placebo or 0.4 mg/kg or 1.2 mg/m(2) of ziprasidone intraperitoneally 30 minutes prior to administration of 105 mg/kg of cocaine. Study outcomes were the proportions of animals having seizures and the apparent lethality.
RESULTS: 1.2 mg/m(2) of ziprasidone decreased the lethal effects of cocaine by 50%, while 0.4 mg/kg decreased lethality by 13%. There was no effect on seizures at either dose.
CONCLUSIONS: Ziprasidone pretreatment decreased lethality in this mouse model of severe cocaine intoxication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860690     DOI: 10.1197/j.aem.2004.12.011

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  3 in total

1.  Knowledge of treatment group does not bias assessment of time to seizure in an animal model of cocaine poisoning.

Authors:  Kennon J Heard; Shay Krier; Nathan R Cleveland
Journal:  Acad Emerg Med       Date:  2010-07       Impact factor: 3.451

2.  Administration of ziprasidone for 10 days increases cocaine toxicity in mice.

Authors:  K Heard; S Krier; N R Zahniser
Journal:  Hum Exp Toxicol       Date:  2008-06       Impact factor: 2.903

3.  Preventative effects of aripiprazole and quetiapine on seizure and lethality in a mice cocaine toxicity model: an experimental study.

Authors:  Atakan Yilmaz; Bulent Erdur; Mert Ozen; Ramazan Sabirli; Ibrahim Turkcuer; Ahmet Sarohan; Murat Seyit
Journal:  J Int Med Res       Date:  2019-06-12       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.